Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hotspot mutations in the structured ENL YEATS domain link aberrant transcriptional condensates and cancer. | Mol Cell | 2022 | 36272410 | PubTator, text mining | PubMed |
| Dynamic 3D Combinatorial Generation of hPSC-Derived Neuromesodermal Organoids With Diverse Regional and Cellular Identities. | Curr Protoc | 2022 | 36264199 | PubTator, text mining | PubMed |
| Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers. | Front Oncol | 2022 | 36263200 | PubTator, text mining | PubMed |
| LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis. | Evid Based Complement Alternat Med | 2022 | 36248434 | PubTator, text mining | PubMed |
| Inhibition of miR-652-3p Regulates Lipid Metabolism and Inflammatory Cytokine Secretion of Macrophages to Alleviate Atherosclerosis by Improving TP53 Expression. | Mediators Inflamm | 2022 | 36248191 | PubTator, text mining | PubMed |
| Nascent polypeptide-Associated Complex and Signal Recognition Particle have cardiac-specific roles in heart development and remodeling. | PLoS Genet | 2022 | 36240221 | PubTator, text mining | PubMed |
| Molecular Biomarkers for the Early Detection of Ovarian Cancer. | Int J Mol Sci | 2022 | 36233339 | PubTator, text mining | PubMed |
| RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy. | Int J Mol Sci | 2022 | 36232714 | PubTator, text mining | PubMed |
| The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer. | Cells | 2022 | 36231036 | PubTator, text mining | PubMed |
| Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer. | Cancers (Basel) | 2022 | 36230805 | PubTator, text mining | PubMed |
| The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab. | Cancers (Basel) | 2022 | 36230519 | PubTator, text mining | PubMed |
| Hox proteins as regulators of extracellular matrix interactions during neural crest migration. | Differentiation | 2022 | 36228422 | PubTator, text mining | PubMed |
| The Wnt/β-catenin signalling pathway in Haematological Neoplasms. | Biomark Res | 2022 | 36224652 | PubTator, text mining | PubMed |
| LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML. | Proc Natl Acad Sci U S A | 2022 | 36215477 | PubTator, text mining | PubMed |
| Severe, but not moderate asthmatics share blood transcriptomic changes with post-traumatic stress disorder and depression. | PLoS One | 2022 | 36206293 | PubTator, text mining | PubMed |
| Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis. | J Exp Clin Cancer Res | 2022 | 36203205 | PubTator, text mining | PubMed |
| SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis. | EBioMedicine | 2022 | 36202053 | PubTator, text mining | PubMed |
| Optical bio-sensing of DNA methylation analysis: an overview of recent progress and future prospects. | RSC Adv | 2022 | 36199327 | PubTator, text mining | PubMed |
| Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia. | iScience | 2022 | 36193052 | PubTator, text mining | PubMed |
| HOXA9 has the hallmarks of a biological switch with implications in blood cancers. | Nat Commun | 2022 | 36192425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=34